We further examined the role of PERK and JNK activation in TAX- or NOC-induced disruption of MMP in human HCT-15 colon cancer cells using the PERK inhibitor GSK and JNK inhibitors SP and JNKI. The gene discussed is MAPK8; the disease is colonic neoplasm.